top of page
About Us
Drive Precision Medicine
Forward
Boston Lighthouse Innovations (BLI) was founded to commercialize the BioBeam Platform, leveraging advanced bioinformatics workflow expertise developed at The Massachusetts General Hospital Center for Integrated Diagnostics (MGH CID). The BioBeam Platform embodies commercial-grade solutions that optimize precision medicine programs and are built on a foundation of proven clinical applications.
​BLI shares with MGH CID a goal to accelerate Clinical genomics.
MGH CID has partnered with BLI to provide consulting and training in the area of molecular pathology workflow design, laboratory management, and variant interpretation.
bottom of page